MemorialCare uses rapid technology to spot hidden brain aneurysms

MemorialCare Neuroscience Institute is using rapid aneurysm technology to spot hidden brain aneurysms, according to a PR Newswire release. The announcement describes the institute as the first in Los Angeles and Orange counties to use the technology.
- MemorialCare Neuroscience Institute is using rapid aneurysm technology.
- The technology is intended to spot hidden brain aneurysms.
- The institute describes itself as the first in Los Angeles and Orange counties to use it.
- The release does not provide technical, clinical, cost, or availability details.
Technology aimed at hidden aneurysms
The announcement centers on the use of rapid aneurysm technology at MemorialCare Neuroscience Institute. Its stated purpose is to spot hidden brain aneurysms, as described in the release title.
A brain aneurysm is referenced in the announcement as the condition the technology is intended to identify. The supplied release text does not provide further details about how the technology works, how quickly it produces results, or how it compares with other approaches.
A first for two Southern California counties
MemorialCare Neuroscience Institute claims a first in Los Angeles and Orange counties through its use of the technology. The announcement does not identify another institution by name or provide additional information about the regional landscape.
The wording establishes the geographic scope of the claim, rather than a broader national or international distinction. It also does not state when the technology began being used or whether it is available at other MemorialCare locations.
What the announcement means for patients
For patients, the release signals that MemorialCare Neuroscience Institute is applying a rapid technology to the detection of hidden brain aneurysms. The source does not say who is eligible for testing, whether a referral is required, or whether the technology changes treatment decisions.
It also provides no information about clinical outcomes, accuracy, costs, insurance coverage, or availability. Those details would be needed to assess the practical impact of the announcement beyond the institute's stated first-in-the-region claim.

